PETER Turner has been appointed
to the NPS MedicineWise Board in
the position of Additional Director
effective 09 December 2012.
Turner comes to the position with
over 40 years experience in the
biopharmaceutical industry both
internationally and domestically,
and his past roles have included
Chairman and board member of
the PPTA (Plasma Protein
Therapeutics Association).
According to NPS, Turner’s
expertise includes international
healthcare, managing global
business expansion, blood plasma
therapies, protein separation
technologies, pharmaceutical
product development and quality
assurance and industrial scale
biotechnology.The above article was sent to subscribers in Pharmacy Daily's issue from 11 Dec 12 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 11 Dec 12
PEAK pharmacy bodies are calling on the Australian Government to extend the new Commonwealth Prac Payment to pharmacy students, citing the challenges of “placement poverty” in unpaid practical placements.
AFT Pharmaceuticals is set to develop a topical treatment for keloid and hypertrophic scarring in partnership with NZ’s Massey Ventures, the commercialisation arm of Massey University, and the Gillies McIndoe Research Institute.
THE Pharmaceutical Society of Australia (PSA) awarded Brooke Shelly the prestigious 2024 PSA MIMS Credentialed Pharmacist of the Year award last Fri at the Credentialed Pharmacist Conference (CPC24) (PD breaking news).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.